Vimarsana
Biggest News Aggregation in the World

Page 21 - Cell Cycle News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Cycle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Cycle Today - Breaking & Trending Today

[Full text] High expression of PIGC in hepatocellular carcinoma - Vimarsana News

[Full text] High expression of PIGC in hepatocellular carcinoma

Disclosure References CA Cancer J Clin. 2019;69:7–34. doi:10.3322/caac.21551 2. Villanueva A. Hepatocellular Carcinoma. N Engl J Med. 2019;380:1450–1462. doi:10.1056/NEJMra1713263 3. Craig AJ, von Felden J, Garcia-Lezana T, Sarcognato S, Villanueva A. Tumour evolution in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2020;17:139–152. doi:10.1038/s41575-019-0229-4 4. Centers For Disease Control And Prevention, Statistics. NCFH. Trends in liver cancer mortality among adults aged 25 and over in the United States, 2000–2016; 2018. 5. Torre LA, Bray F, Siegel RL, Ferlay J, Lort...

MEI Pharma to Present Study at the American Association for Cancer Research (AACR) Annual Meeting 2021 Demonstrating that Voruciclib Inhibits KRAS Mutant Cancers in Pre-Clinical Models - Vimarsana News

MEI Pharma to Present Study at the American Association for Cancer Research (AACR) Annual Meeting 2021 Demonstrating that Voruciclib Inhibits KRAS Mutant Cancers in Pre-Clinical Models

Share this article Share this article SAN DIEGO, March 10, 2021 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that the abstract, Voruciclib, a CDK9 inhibitor, downregulates MYC and inhibits proliferation of KRAS mutant cancers in preclinical models, was selected for an E-Poster Session presentation at the American Association for Cancer Research (AACR) Annual Meeting 2021 and will be available on April 10, 2021. Voruciclib is an orally available inhibitor of cyclin-dependent kinase 9 (CDK9...

Apoptosis is an important mediator of pathogenesis in animal coronavirus infection - Vimarsana News

Apoptosis is an important mediator of pathogenesis in animal coronavirus infection

Apoptosis is an important mediator of pathogenesis in animal coronavirus infection Apoptosis is a form of programmed cell death, which occurs in cells that are irreparably damaged or in cells infected by some viruses. This mechanism is extremely important in limiting a virus’s replication and its spread to other neighboring cells. A new paper in the journal Lifepresents an early review of the viral factors involved in initiating and effecting apoptosis within infected cells. Colorized scanning electron micrograph of an apoptotic cell (blue) infected with SARS-COV-2 virus particles (red), i...

Novel host-viral-microbiome interactions during COVID-19 may determine outcome - Vimarsana News

Novel host-viral-microbiome interactions during COVID-19 may determine outcome

Novel host-viral-microbiome interactions during COVID-19 may determine outcome The current pandemic of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been spreading rapidly for over a year. Though primarily a respiratory illness, its manifestations are often protean and may be life-threatening. A new preprint on the medRxiv* server discusses how the underlying disease mechanisms are regulated such that the local or mucosal immune response is distinct from the systemic response. Viral suppression of innate but not adaptive ...

GLS1 inhibitor selectively eliminates senescent cells, ameliorates age-associated disorders - Vimarsana News

GLS1 inhibitor selectively eliminates senescent cells, ameliorates age-associated disorders

GLS1 inhibitor selectively eliminates senescent cells, ameliorates age-associated disorders Senescent cells accumulate in organs during aging, promote tissue dysfunction, and cause numerous aging-related diseases like cancer. The cells arise through a process called "cellular senescence," a permanent cell cycle arrest resulting from multiple stresses. A collaborative research group led by Professor Makoto Nakanishi of the Institute of Medical Science, The University of Tokyo (IMSUT), and co-researchers have identified an inhibitor of the glutamate metabolic enzyme GLS1so that its administrati...